285 related articles for article (PubMed ID: 26508820)
1. Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia.
Ebadi M; Mazurak VC
Mediators Inflamm; 2015; 2015():820934. PubMed ID: 26508820
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients.
Batista ML; Olivan M; Alcantara PS; Sandoval R; Peres SB; Neves RX; Silverio R; Maximiano LF; Otoch JP; Seelaender M
Cytokine; 2013 Feb; 61(2):532-9. PubMed ID: 23200412
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a novel serum factor distinct from zinc alpha-2 glycoprotein that promotes body fat loss early in the development of cachexia.
Byerley LO; Lee SH; Redmann S; Culberson C; Clemens M; Lively MO
Nutr Cancer; 2010; 62(4):484-94. PubMed ID: 20432169
[TBL] [Abstract][Full Text] [Related]
4. Zinc-α2-glycoprotein as a marker of fat catabolism in humans.
Cabassi A; Tedeschi S
Curr Opin Clin Nutr Metab Care; 2013 May; 16(3):267-71. PubMed ID: 23448999
[TBL] [Abstract][Full Text] [Related]
5. Regulation of adipose tissue metabolism in cancer cachexia.
Bing C; Trayhurn P
Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):201-7. PubMed ID: 18403913
[TBL] [Abstract][Full Text] [Related]
6. New insights into adipose tissue atrophy in cancer cachexia.
Bing C; Trayhurn P
Proc Nutr Soc; 2009 Nov; 68(4):385-92. PubMed ID: 19719894
[TBL] [Abstract][Full Text] [Related]
7. Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia.
Tsoli M; Swarbrick MM; Robertson GR
Semin Cell Dev Biol; 2016 Jun; 54():68-81. PubMed ID: 26529279
[TBL] [Abstract][Full Text] [Related]
8. Evidence and mechanisms of fat depletion in cancer.
Ebadi M; Mazurak VC
Nutrients; 2014 Nov; 6(11):5280-97. PubMed ID: 25415607
[TBL] [Abstract][Full Text] [Related]
9. Lipid mobilization in cachexia: mechanisms and mediators.
Bing C
Curr Opin Support Palliat Care; 2011 Dec; 5(4):356-60. PubMed ID: 21934502
[TBL] [Abstract][Full Text] [Related]
10. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients.
Mracek T; Stephens NA; Gao D; Bao Y; Ross JA; Rydén M; Arner P; Trayhurn P; Fearon KC; Bing C
Br J Cancer; 2011 Feb; 104(3):441-7. PubMed ID: 21245862
[TBL] [Abstract][Full Text] [Related]
11. Lipolysis--not inflammation, cell death, or lipogenesis--is involved in adipose tissue loss in cancer cachexia.
Rydén M; Agustsson T; Laurencikiene J; Britton T; Sjölin E; Isaksson B; Permert J; Arner P
Cancer; 2008 Oct; 113(7):1695-704. PubMed ID: 18704987
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia.
Batista ML; Neves RX; Peres SB; Yamashita AS; Shida CS; Farmer SR; Seelaender M
J Endocrinol; 2012 Dec; 215(3):363-73. PubMed ID: 23033362
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors.
Batista ML; Peres SB; McDonald ME; Alcantara PS; Olivan M; Otoch JP; Farmer SR; Seelaender M
Cytokine; 2012 Jan; 57(1):9-16. PubMed ID: 22099872
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
15. Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation.
Tsoli M; Schweiger M; Vanniasinghe AS; Painter A; Zechner R; Clarke S; Robertson G
PLoS One; 2014; 9(3):e92966. PubMed ID: 24667661
[TBL] [Abstract][Full Text] [Related]
16. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients.
Murphy RA; Wilke MS; Perrine M; Pawlowicz M; Mourtzakis M; Lieffers JR; Maneshgar M; Bruera E; Clandinin MT; Baracos VE; Mazurak VC
Clin Nutr; 2010 Aug; 29(4):482-7. PubMed ID: 19959263
[TBL] [Abstract][Full Text] [Related]
17. Cancer Cachexia and MicroRNAs.
Camargo RG; Quintas Teixeira Ribeiro H; Geraldo MV; Matos-Neto E; Neves RX; Carnevali LC; Donatto FF; Alcântara PS; Ottoch JP; Seelaender M
Mediators Inflamm; 2015; 2015():367561. PubMed ID: 26504359
[TBL] [Abstract][Full Text] [Related]
18. Hypoleptinemia in gastric cancer patients: relation to body fat mass, insulin, and growth hormone.
Huang Q; Zhang X; Jiang ZW; Liu BZ; Li N; Li JS
JPEN J Parenter Enteral Nutr; 2005; 29(4):229-35. PubMed ID: 15961677
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue rearrangement in cancer cachexia: The involvement of β3-adrenergic receptor associated pathways.
Mota INR; Satari S; Marques IS; Santos JMO; Medeiros R
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189103. PubMed ID: 38679401
[TBL] [Abstract][Full Text] [Related]
20. Zinc-alpha2-glycoprotein in cachexia and obesity.
Tisdale MJ
Curr Opin Support Palliat Care; 2009 Dec; 3(4):288-93. PubMed ID: 19823091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
